Aimmune Stock Flies On First-Of-Its-Kind Peanut Allergy Approval
Artificial intelligence stocks are rarer than you might think. Many companies tout AI technology initiatives and machine learning.
Feb-3-2020, 18:03:29 GMT
- Industry:
- Health & Medicine > Therapeutic Area
- Immunology > Allergy (0.40)
- Media > News (0.69)
- Health & Medicine > Therapeutic Area
- Technology: